Erica Spatz is a Cardiology physician affiliated with Yale New Haven Hospital. OpenAlex indexes 510 publications with 13,435 citations (h-index 57); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Cedar St
Dana 3 Building
New Haven, CT 065103218
Telephone
203-785-6484Registry record last updated 2 Jul 2013.
Clinical trials
- PRESSURE CHECK: Find Your Path to Better Health
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20252 payments
- Regeneron Pharmaceuticals, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.3%Statin21.4%Rosuvastatin Calcium61%Atorvastatin Calcium36%Simvastatin4%Part D<11 patientsBeta blocker16.5%Metoprolol Succinate44%Carvedilol40%Metoprolol Tartrate10%Propranolol Hcl Er6%Part D<11 patients+ 13 more classes in this area
Blood & clotting
10.9%Factor Xa inhibitor6.8%Eliquis82%Xarelto18%Part D<11 patientsP2Y12 inhibitor4.1%Clopidogrel100%Part D≥21 patientsMetabolism & gastrointestinal
6.8%SGLT2 inhibitor3%Jardiance61%Farxiga39%Part D<11 patientsGLP-1 receptor agonist3%Ozempic66%Mounjaro34%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2017–2020 per NIH RePORTER. The latest:
- Health Disparities in Hypertension: A Precision Medicine-based Approach for Early Risk Stratification and Prevention
Yale University
FY2020$340,385U54MD010711 - Health Disparities in Hypertension: A Precision Medicine-based Approach for Early Risk Stratification and Prevention
Yale University
FY2019$374,139U54MD010711 - Health Disparities in Hypertension: A Precision Medicine-based Approach for Early Risk Stratification and Prevention
Yale University
FY2018$375,724U54MD010711
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
New England Journal of Medicine
2024 - 2022 ACC/AHA guideline for the diagnosis and management of aortic disease
Journal of Thoracic and Cardiovascular Surgery
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Sanacora, MD, PhD
Yale New Haven Hospital
John Elefteriades, MD
Yale New Haven Hospital
Jeptha Curtis, MD
Yale New Haven Hospital
Rohan Khera, MD
Yale New Haven Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”